Europe’s medical devices industry saw a rise of 12.50% in cross border deal activity during June 2022, when compared with the last 12-month average, led by ResMed’s $1bn acquisition of MediFox DAN Group, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 27 medical devices industry cross border deals worth $2.1bn were announced for the region in June 2022, against the 12-month average of 24 deals.

Of all the deal types, M&A saw most activity in June 2022 with 13 transactions, representing a 48.2% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was venture financing with 11 deals, followed by private equity deals with three transactions, respectively capturing a 40.7% and 11.1% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in Europe’s medical devices industry with $1.13bn, while private equity and venture financing deals totalled $837.86m and $169.15m, respectively.

Europe medical devices industry cross border deals in June 2022: Top deals

The top five medical devices cross border deals accounted for 94% of the overall value during June 2022.

The combined value of the top five medical devices cross border deals stood at $2.01bn, against the overall value of $2.1bn recorded for the month.

The top five medical devices industry cross border deals of June 2022 tracked by GlobalData were:

1) ResMed $1bn acquisition deal with MediFox DAN Group

2) The $797.86m private equity of SPT Labtech by EQT IX Fund

3) Azenta $85.5m acquisition deal with Barkey GmbHKG

4) The $80m venture financing of Proximie by Advent Life Sciences,British Patient Capital,Eight Roads Ventures,Emerson Collective,F Prime Capital,Global ventures,Maverick Ventures Israel,Minderoo Foundation,Mubadala Investment,Questa Capital Management and SoftBank Vision Fund 2

5) Fujirebio $42.15m acquisition deal with ADx NeuroSciences